Copyright Reports & Markets. All rights reserved.

Global Liposomal DDS Technology Market Growth (Status and Outlook) 2022-2028

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Liposomal DDS Technology Market Size 2017-2028
    • 2.1.2 Liposomal DDS Technology Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Liposomal DDS Technology Segment by Type
    • 2.2.1 Liposomal Doxorubicin
    • 2.2.2 Liposomal Amphoteracin B
    • 2.2.3 Liposomal Paclitaxel
    • 2.2.4 Others
  • 2.3 Liposomal DDS Technology Market Size by Type
    • 2.3.1 Liposomal DDS Technology Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Liposomal DDS Technology Market Size Market Share by Type (2017-2022)
  • 2.4 Liposomal DDS Technology Segment by Application
    • 2.4.1 Fungal Infection Therapy
    • 2.4.2 Cancer & Tumor Therapy
    • 2.4.3 Others
  • 2.5 Liposomal DDS Technology Market Size by Application
    • 2.5.1 Liposomal DDS Technology Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Liposomal DDS Technology Market Size Market Share by Application (2017-2022)

3 Liposomal DDS Technology Market Size by Player

  • 3.1 Liposomal DDS Technology Market Size Market Share by Players
    • 3.1.1 Global Liposomal DDS Technology Revenue by Players (2020-2022)
    • 3.1.2 Global Liposomal DDS Technology Revenue Market Share by Players (2020-2022)
  • 3.2 Global Liposomal DDS Technology Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Liposomal DDS Technology by Regions

  • 4.1 Liposomal DDS Technology Market Size by Regions (2017-2022)
  • 4.2 Americas Liposomal DDS Technology Market Size Growth (2017-2022)
  • 4.3 APAC Liposomal DDS Technology Market Size Growth (2017-2022)
  • 4.4 Europe Liposomal DDS Technology Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Liposomal DDS Technology Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Liposomal DDS Technology Market Size by Country (2017-2022)
  • 5.2 Americas Liposomal DDS Technology Market Size by Type (2017-2022)
  • 5.3 Americas Liposomal DDS Technology Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Liposomal DDS Technology Market Size by Region (2017-2022)
  • 6.2 APAC Liposomal DDS Technology Market Size by Type (2017-2022)
  • 6.3 APAC Liposomal DDS Technology Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Liposomal DDS Technology by Country (2017-2022)
  • 7.2 Europe Liposomal DDS Technology Market Size by Type (2017-2022)
  • 7.3 Europe Liposomal DDS Technology Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Liposomal DDS Technology by Region (2017-2022)
  • 8.2 Middle East & Africa Liposomal DDS Technology Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Liposomal DDS Technology Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Liposomal DDS Technology Market Forecast

  • 10.1 Global Liposomal DDS Technology Forecast by Regions (2023-2028)
    • 10.1.1 Global Liposomal DDS Technology Forecast by Regions (2023-2028)
    • 10.1.2 Americas Liposomal DDS Technology Forecast
    • 10.1.3 APAC Liposomal DDS Technology Forecast
    • 10.1.4 Europe Liposomal DDS Technology Forecast
    • 10.1.5 Middle East & Africa Liposomal DDS Technology Forecast
  • 10.2 Americas Liposomal DDS Technology Forecast by Country (2023-2028)
    • 10.2.1 United States Liposomal DDS Technology Market Forecast
    • 10.2.2 Canada Liposomal DDS Technology Market Forecast
    • 10.2.3 Mexico Liposomal DDS Technology Market Forecast
    • 10.2.4 Brazil Liposomal DDS Technology Market Forecast
  • 10.3 APAC Liposomal DDS Technology Forecast by Region (2023-2028)
    • 10.3.1 China Liposomal DDS Technology Market Forecast
    • 10.3.2 Japan Liposomal DDS Technology Market Forecast
    • 10.3.3 Korea Liposomal DDS Technology Market Forecast
    • 10.3.4 Southeast Asia Liposomal DDS Technology Market Forecast
    • 10.3.5 India Liposomal DDS Technology Market Forecast
    • 10.3.6 Australia Liposomal DDS Technology Market Forecast
  • 10.4 Europe Liposomal DDS Technology Forecast by Country (2023-2028)
    • 10.4.1 Germany Liposomal DDS Technology Market Forecast
    • 10.4.2 France Liposomal DDS Technology Market Forecast
    • 10.4.3 UK Liposomal DDS Technology Market Forecast
    • 10.4.4 Italy Liposomal DDS Technology Market Forecast
    • 10.4.5 Russia Liposomal DDS Technology Market Forecast
  • 10.5 Middle East & Africa Liposomal DDS Technology Forecast by Region (2023-2028)
    • 10.5.1 Egypt Liposomal DDS Technology Market Forecast
    • 10.5.2 South Africa Liposomal DDS Technology Market Forecast
    • 10.5.3 Israel Liposomal DDS Technology Market Forecast
    • 10.5.4 Turkey Liposomal DDS Technology Market Forecast
    • 10.5.5 GCC Countries Liposomal DDS Technology Market Forecast
  • 10.6 Global Liposomal DDS Technology Forecast by Type (2023-2028)
  • 10.7 Global Liposomal DDS Technology Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 Gilead Sciences
    • 11.1.1 Gilead Sciences Company Information
    • 11.1.2 Gilead Sciences Liposomal DDS Technology Product Offered
    • 11.1.3 Gilead Sciences Liposomal DDS Technology Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 Gilead Sciences Main Business Overview
    • 11.1.5 Gilead Sciences Latest Developments
  • 11.2 Pacira
    • 11.2.1 Pacira Company Information
    • 11.2.2 Pacira Liposomal DDS Technology Product Offered
    • 11.2.3 Pacira Liposomal DDS Technology Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 Pacira Main Business Overview
    • 11.2.5 Pacira Latest Developments
  • 11.3 Sun Pharmaceutical
    • 11.3.1 Sun Pharmaceutical Company Information
    • 11.3.2 Sun Pharmaceutical Liposomal DDS Technology Product Offered
    • 11.3.3 Sun Pharmaceutical Liposomal DDS Technology Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 Sun Pharmaceutical Main Business Overview
    • 11.3.5 Sun Pharmaceutical Latest Developments
  • 11.4 Johnson & Johnson
    • 11.4.1 Johnson & Johnson Company Information
    • 11.4.2 Johnson & Johnson Liposomal DDS Technology Product Offered
    • 11.4.3 Johnson & Johnson Liposomal DDS Technology Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 Johnson & Johnson Main Business Overview
    • 11.4.5 Johnson & Johnson Latest Developments
  • 11.5 Luye Pharma
    • 11.5.1 Luye Pharma Company Information
    • 11.5.2 Luye Pharma Liposomal DDS Technology Product Offered
    • 11.5.3 Luye Pharma Liposomal DDS Technology Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 Luye Pharma Main Business Overview
    • 11.5.5 Luye Pharma Latest Developments
  • 11.6 Sigma-Tau
    • 11.6.1 Sigma-Tau Company Information
    • 11.6.2 Sigma-Tau Liposomal DDS Technology Product Offered
    • 11.6.3 Sigma-Tau Liposomal DDS Technology Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 Sigma-Tau Main Business Overview
    • 11.6.5 Sigma-Tau Latest Developments
  • 11.7 Ipsen (Onivyde)
    • 11.7.1 Ipsen (Onivyde) Company Information
    • 11.7.2 Ipsen (Onivyde) Liposomal DDS Technology Product Offered
    • 11.7.3 Ipsen (Onivyde) Liposomal DDS Technology Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Ipsen (Onivyde) Main Business Overview
    • 11.7.5 Ipsen (Onivyde) Latest Developments
  • 11.8 CSPC
    • 11.8.1 CSPC Company Information
    • 11.8.2 CSPC Liposomal DDS Technology Product Offered
    • 11.8.3 CSPC Liposomal DDS Technology Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 CSPC Main Business Overview
    • 11.8.5 CSPC Latest Developments
  • 11.9 Teva Pharmaceutical
    • 11.9.1 Teva Pharmaceutical Company Information
    • 11.9.2 Teva Pharmaceutical Liposomal DDS Technology Product Offered
    • 11.9.3 Teva Pharmaceutical Liposomal DDS Technology Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 Teva Pharmaceutical Main Business Overview
    • 11.9.5 Teva Pharmaceutical Latest Developments
  • 11.10 Novartis
    • 11.10.1 Novartis Company Information
    • 11.10.2 Novartis Liposomal DDS Technology Product Offered
    • 11.10.3 Novartis Liposomal DDS Technology Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 Novartis Main Business Overview
    • 11.10.5 Novartis Latest Developments
  • 11.11 Fudan-Zhangjiang
    • 11.11.1 Fudan-Zhangjiang Company Information
    • 11.11.2 Fudan-Zhangjiang Liposomal DDS Technology Product Offered
    • 11.11.3 Fudan-Zhangjiang Liposomal DDS Technology Revenue, Gross Margin and Market Share (2020-2022)
    • 11.11.4 Fudan-Zhangjiang Main Business Overview
    • 11.11.5 Fudan-Zhangjiang Latest Developments

12 Research Findings and Conclusion

As the global economy mends, the 2021 growth of Liposomal DDS Technology will have significant change from previous year. According to our (LP Information) latest study, the global Liposomal DDS Technology market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Liposomal DDS Technology market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Liposomal DDS Technology market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Liposomal DDS Technology market, reaching US$ million by the year 2028. As for the Europe Liposomal DDS Technology landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Liposomal DDS Technology players cover Gilead Sciences, Pacira, Sun Pharmaceutical, and Johnson & Johnson, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Liposomal DDS Technology market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Fungal Infection Therapy
Cancer & Tumor Therapy
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Gilead Sciences
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma-Tau
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang
Buy now